Point72 Asset Management
GH icon

Point72 Asset Management’s Guardant Health GH Stock Holding History

Point72 Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$933K Buy
+10,100
New +$1.01M ﹤0.01% 2805
2024
Q2 		– Sell
-45,000
Closed -$928K – 2071
2024
Q1 		$928K Sell
45,000
-25,000
-36% -$536K ﹤0.01% 1481
2023
Q4 		$1.89M Buy
+70,000
New +$1.84M ﹤0.01% 1228
2023
Q1 		– Sell
-12,500
Closed -$340K – 2353
2022
Q4 		$340K Buy
+12,500
New +$572K ﹤0.01% 1196

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's GH Position: Q1 2026 in Review

Point72 Asset Management reduced its Guardant Health (GH) stake by 54% in Q1 2026, selling an estimated $80.6M and leaving 695,940 shares worth $64.3M. The position accounts for 0.08% of the portfolio, ranked #282.

Point72 Asset Management first reported a position in GH in Q1 2019 and has held it in 19 quarters since. The position peaked at $153M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Point72 Asset Management held 695,940 shares of Guardant Health worth $64.3M as of Q1 2026.
  • Point72 Asset Management sold 803,229 Guardant Health shares in Q1 2026, an estimated $80.6M.
  • Guardant Health made up 0.08% of Point72 Asset Management's portfolio in Q1 2026, its #282 holding.
  • Point72 Asset Management first reported a position in Guardant Health in Q1 2019 and has held it in 19 quarters since.
  • Point72 Asset Management's Guardant Health position peaked at $153M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.